Jiangsu Kanion Pharma is a pharmaceuticals company based out of LIANYUNGANG. Jiangsu Kanion Pharma representatives, don’t miss out on opportunities to build relationships with members on LinkedIn. Claim your page, write a simple description, and share content to attract followers that can lead to new customers, brand fans, and future employees.

Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including hepatitis A and B, seasonal influenza, H5N1 pandemic influenza (avian flu), H1N1 influenza (swine flu), and mumps, as well as animal rabies vaccine for canines. In 2009, Sinovac was the first company worldwide to receive approval for its H1N1 influenza vaccine, Panflu.1, and has manufactured it for the Chinese Central Government, pursuant to the government-stockpiling program. The company is also the only supplier of the H5N1 pandemic influenza vaccine to the government-stockpiling program. Sinovac is developing a number of new pipeline vaccines including vaccines for enterovirus 71 (against hand, foot, and mouth disease), of which the EV71 vaccine is currently in Phase III clinical trials, pneumococcal conjugate, pneumococcal polysaccharides, and rubella. Sinovac sells its vaccines mainly in China and exports selected vaccines to Mongolia, Nepal, and the Philippines.

Takeda Vaccines, Inc., a subsidiary of Takeda Pharmaceutical Co., Ltd., is an American company located in Bozeman, MT. The firm provides biological research and development services.

Tianjin International Biomedical Joint Research Institute Co., Ltd., established on 2010-05-18, Business scope includes scientific and technological research and development and related consulting;Biotechnology R&D and Application;R&D and pilot test of pharmaceutical products,analysis test,Technical Services,information service;Financing Consulting;Business Consulting;House to rent;financial services;Tax agency service;Conference Services;Technology intermediary service;Daily necessities,Wholesale and retail of experimental instruments;laboratory equipment(Does not contain medical devices)research and development,Sales;laboratory materials(Does not contain food,medicine,Hazardous Chemicals and Precursors)promotion of;Wholesale and retail of prepackaged food;Entrusted to provide business services for enterprises.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Tokyo Metropolitan Institute of Medical Science is a Japanese private company. The firm operates as a research institute that develops medicine.

Jiangsu Convac Biotechnology Co., Ltd. engages in the research and development, production, and sale of biological products. It offers new vaccines, genetic modified drugs and in vitro diagnostic reagents. The company was founded on October 13, 2011 and is headquartered in Taizhou, China.

Institute of Laboratory Animal Science, a subsidiary of University of Zurich, is a Swiss company located in Schlieren that provides research, services and teaching in translational and basic research.

Beijing Anbaisheng Biotechnology Co., Ltd., established on 2011-03-07, Business scope includes technology development,technical consulting,Technical Services,technology transfer;Sales of chemical products(Does not contain a class of precursor chemicals and dangerous chemicals);Import and export.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Recbio, founded in 2012, is an innovative vaccine company based on independent research and development technology. It is dedicated to establishing a full value chain for innovative vaccines, including research and development, manufacturing, and commercialization. The company has always adhered to its mission of "creating first-class vaccines and protecting human health". With a strong R&D engine comprised of novel adjuvants, protein engineering, immunological evaluation, and other core technology platforms, the company is strategically focusing on disease areas with high burdens such as cervical cancers.

Beijing Helmer Technology Co., Ltd., established on 2016-12-23, Business scope includes technology development,Technology Promotion,technology transfer,technical consulting,Technical Services;Computer System Services;Basic software service;Application software service(Does not contain medical software);software development;product design;model design;Packaging and decoration design;Economic and Trade Consulting;public relations service;Conference Services;arts and crafts design;computer graphic design,make;buisness planning;design,make,acting,Place an ad;market survey;Business Management Consulting;Organize cultural and artistic exchange activities(without show);literary creation;Undertake exhibition and display activities;translation service;natural science research;Engineering and Technology Studies;agricultural science research;Medical Research(Does not include medical activities);data processing(Bank Card Center in Data Processing,PUEvalue in1;5Except for the above cloud computing data centers);Sales instrumentation,Iclass of medical devices,metallic material,feed.(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

Bavarian Nordic A/S focuses on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases. It specializes in cancer immunotherapy which includes cancer pipeline, which focuses on therapeutic vaccines for breast, lung, ovarian and prostate cancer. Its products include IMVAMUNE for Ebola, HPV, HBV, and HIV diseases. The company was founded in 1994 and is headquartered in Kvistgaard, Denmark.

Siao Biotechnology Suzhou Co. Ltd. is a company headquartered in Suzhou, China, that engages in the research and development and production of veterinary, aquatic vaccines and pesticides. The firm was founded in 2012.

Honz Pharmaceutical Co., Ltd. engages in the manufacture and distribution of drugs for children. It offers western medicines and Chinese patent drugs, including antipyretic and analgesic drugs, cold drugs, antibiotics drugs, respiratory system drugs, digestant, and arresting convulsion drugs. Its products include nimesulide granules, cefminox sodium for injection, zhike juhong granules, ganmao qingre granules, artificial cow-bezoar and chlorphenamine maleate granules, cefaclor granules, carbocisteine granules, jianerle granules, pediatric vitamins, calcium gluconate granules, ribavirin pellets, and Norfloxacin capsules for adults. The company was founded on January 20, 1994 and is headquartered in Guangzhou, China.

Zhongke Biopharmaceutical Co. Ltd. is a Chinese private company located in Beijing. The firm manufactures vaccination products.

Xiamen Innovax Biotech Co., Ltd. manufactures vaccines and diagnostic reagents. It focuses on research and development, manufacturing, marketing of vaccine, diagnosis kit and medical equipment. The company was founded in 2005 and is headquartered in Xiamen, China.

Shandong ACV Biotech Co. Ltd. engages in the research and development, promotion, and service of clinical biomedical and laboratory molecular biology products. Its products include multiplex amplification detection reagent, immune repertoire multiple, amplification reagent,ACV-Plex detection reagent, fluorescence quantitative PCR detection reagents, basic biology reagents, and automated instrument, The company was founded on March 16, 2007 and is headquartered in Jinan, China.

Hainan MeilanShiKline Pharmaceutical Co., Ltd., established on 2002-01-24, Business scope includes licensed projects:pharmaceutical production;Pharmaceutical commissioned production;Drug Wholesale;Class III medical device business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)General project:Non-residential real estate leases;property management(Except for licensed business,Can independently operate projects that are not prohibited or restricted by laws and regulations)(General operating items self-management,Licensed business projects are operated on the basis of relevant licenses or approval documents)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

Hualan Biological Engineering is a key National high-tech biopharmaceutical company in China engaging in the research, development, production, and commercialization of plasma products, viral vaccines, bacterial vaccines, and recombinant proteins and other biologics. The plasma products offered by the company include Human albumin, Human fibrinogen, Human tetanus immunoglobulin and others. The vaccines products include Recombinant hepatitis B vaccine, Inactivated influenza vaccine and other. It also offers gene products such as Monoclonal Antibody for tumor, autoimmune diseases, infectious diseases, transplant rejection, and Recombinant monoclonal antibodies.